Fidelity Investments’s Pliant Therapeutics PLRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$7.55K Sell
6,507
-15,703
-71% -$18.2K ﹤0.01% 4608
2025
Q1
$30K Sell
22,210
-3,854,388
-99% -$5.2M ﹤0.01% 4076
2024
Q4
$51.1M Sell
3,876,598
-22,883
-0.6% -$301K ﹤0.01% 1373
2024
Q3
$43.7M Sell
3,899,481
-12,278
-0.3% -$138K ﹤0.01% 1433
2024
Q2
$42.1M Sell
3,911,759
-34,738
-0.9% -$373K ﹤0.01% 1377
2024
Q1
$58.8M Sell
3,946,497
-16,921
-0.4% -$252K ﹤0.01% 1264
2023
Q4
$71.8M Sell
3,963,418
-177,586
-4% -$3.22M 0.01% 1147
2023
Q3
$71.8M Sell
4,141,004
-101,019
-2% -$1.75M 0.01% 1111
2023
Q2
$76.9M Sell
4,242,023
-289,492
-6% -$5.25M 0.01% 1104
2023
Q1
$121M Buy
4,531,515
+138,284
+3% +$3.68M 0.01% 919
2022
Q4
$84.9M Sell
4,393,231
-1,693,262
-28% -$32.7M 0.01% 1031
2022
Q3
$127M Buy
6,086,493
+2,744,222
+82% +$57.3M 0.01% 868
2022
Q2
$26.8M Sell
3,342,271
-1,733,054
-34% -$13.9M ﹤0.01% 1537
2022
Q1
$35.6M Sell
5,075,325
-330,524
-6% -$2.32M ﹤0.01% 1539
2021
Q4
$73M Buy
5,405,849
+15,159
+0.3% +$205K 0.01% 1261
2021
Q3
$91M Buy
5,390,690
+6,522
+0.1% +$110K 0.01% 1146
2021
Q2
$157M Buy
5,384,168
+23,440
+0.4% +$683K 0.01% 913
2021
Q1
$211M Buy
5,360,728
+38,572
+0.7% +$1.52M 0.02% 767
2020
Q4
$121M Buy
5,322,156
+5,640
+0.1% +$128K 0.01% 951
2020
Q3
$120M Sell
5,316,516
-16,185
-0.3% -$367K 0.01% 826
2020
Q2
$173M Buy
+5,332,701
New +$173M 0.02% 661